Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5932266 | 0.90 | — | — | |
| SCHEMBL11309332 | 0.87 | CYP1A2 (0.37) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL42070 | 0.84 | — | — | |
| SCHEMBL3996586 | 0.84 | — | — | |
| SCHEMBL11555092 | 0.82 | — | — | |
| Dimethylamine SCHEMBL5605144 | 0.82 | CYP1A2 (0.34) | TSHRTDP1THPOMAPTEHMT2 | |
| Hydrochloric Acid SCHEMBL25414584 | 0.81 | — | — | |
| SCHEMBL12570288 | 0.81 | TDP1 (0.40) | ALDH1A1TDP1NOS3NOS1NOS2 | |
| SCHEMBL10122628 | 0.81 | TDP1 (0.40) | ALDH1A1TDP1NOS3NOS1NOS2 | |
| SCHEMBL10122625 | 0.81 | TDP1 (0.40) | ALDH1A1TDP1NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190176124-A1 | POLYORGANIC FUNCTIONAL GROUPS MODIFIED SILICA, PROCESSES TO MAKE AND USE THEREOF | SI-NOVATION LTD (CN) | 2019-06-13 | — | — | US | disclosed |
| EP-3344683-A1 | POLYORGANIC FUNCTIONAL GROUPS MODIFIED SILICA, PROCESSES TO MAKE AND USE THEREOF | Si-Novation Ltd (CN) | 2018-07-11 | — | — | EP | disclosed |
| WO-2017036268-A1 | POLYORGANIC FUNCTIONAL GROUPS MODIFIED SILICA, PROCESSES TO MAKE AND USE THEREOF | SI-NOVATION LTD (CN) | 2017-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190176124-A1 | POLYORGANIC FUNCTIONAL GROUPS MODIFIED SILICA, PROCESSES TO MAKE AND USE THEREOF | STAMBP, TST, AS3MT | DNM1 4716/4885TSHR 1120/4885MEN1 4240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.